General Information
DRAVP ID DRAVPe01088
Peptide Name 13(derived from HCV C5A)
Sequence CEVLSDFK
Sequence Length 8
UniProt ID P26664
Source Synthetic construct(derived from HCV non-structural protein 5A)
Activity Information
Target Organism HCV
Assay RT-QPCR assay
Activity
Hemolytic Activity No hemolysis information or data found in the reference(s) presented in this entry
Cytotoxicity No cytotoxicity information found in the reference(s) presented
Binding Target membrane
Mechanism The peptide destabilizes viral structural integrity and has viral membranolytic activity.It interacts with the viral membrane to disrupt its integrity, release viral capsids, and expose the viral genome to exonucleases for degradation.
Structure Information
PDB ID None
Predicted Structure Download DRAVPe01088
Linear/Cyclic Linear
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Stereochemistry L
Physicochemical Information
Formula C41H65N9O14S
Absent amino acids AGHIMNPQRTWY
Common amino acids CDEFKLSV
Mass 940.08
Pl 4.37
Basic residues 1
Acidic residues 2
Hydrophobic residues 3
Net charge -1
Boman Index -1126
Hydrophobicity 20
Aliphatic Index 85
Half Life
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 2
Literature Information
Literature 1
Title A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.
Pubmed ID 18287023
Reference Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):3088-93.
Author Cheng G, Montero A, Gastaminza P, Whitten-Bauer C, Wieland SF, Isogawa M, Fredericksen B, Selvarajah S, Gallay PA, Ghadiri MR, Chisari FV.